BBIO
USDBridgeBio Pharma Inc. Common Stock
リアルタイム価格
価格チャート
主要指標
市場指標
始値
$61.420
高値
$61.905
安値
$60.230
出来高
2.10M
企業ファンダメンタルズ
時価総額
11.8B
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
2.63M
取引所
NMS
通貨
USD
52週レンジ
関連ニュース
BridgeBio to Participate in November Investor Conferences
PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today announced that
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten
HC Wainwright & Co. Reiterates Buy on BridgeBio Pharma, Maintains $90 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BridgeBio Pharma with a Buy and maintains $90 price target.
Goldman Sachs Maintains Buy on BridgeBio Pharma, Raises Price Target to $100
Goldman Sachs analyst Paul Choi maintains BridgeBio Pharma with a Buy and raises the price target from $55 to $100.
TD Cowen Maintains Buy on BridgeBio Pharma, Raises Price Target to $95
TD Cowen analyst Tyler Van Buren maintains BridgeBio Pharma with a Buy and raises the price target from $60 to $95.
Raymond James Reiterates Outperform on BridgeBio Pharma, Raises Price Target to $71
Raymond James analyst Martin Auster reiterates BridgeBio Pharma with a Outperform and raises the price target from $69 to $71.
Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $110
Cantor Fitzgerald analyst Josh Schimmer maintains BridgeBio Pharma with a Overweight and raises the price target from $100 to $110.
関連株式
最新情報を入手
価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。